Huaheng Bioharbor's listing on the stock market has been filed with the China Securities Regulatory Commission.

The International Cooperation Department of the China Securities Regulatory Commission issued a notice on the overseas issuance and listing filing of Anhui Huaheng Biotechnology Co., Ltd., stating that the company plans to issue no more than 31,959,300 shares of overseas listed common stock and list on the Hong Kong Stock Exchange.